ET1 activates the mitogen-activated protein kinase (MAPK) pathway through ET receptor signaling and subsequently modulates cell survival, proliferation, invasion and angiogenesis (reviewed by Rosano et al.6) and is implicated in numerous cancers. The gene discussed is EDN1; the disease is cancer.